Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial - Concepedia

Concepedia

Publication | Closed Access

Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial

96

Citations

47

References

2018

Year

Sandra A. Springer, Angela Di Paola, Marwan M. Azar, Russell Barbour, Breanne E. Biondi, Maureen Desabrais, Thomas Lincoln, Daniel J. Skiest, Frederick L. Altice

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

XR-NTX improves or maintains VS after release to the community for incarcerated people living with HIV with OUD.

References

	Year	Citations

Page 1